Lauroyl-gemcitabine loaded lipid nanocapsules for the treatment of metastases in mediastinal lymph nodes

(1)

HAL Id: hal-03173099

https://hal.univ-angers.fr/hal-03173099

Submitted on 18 Mar 2021

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

Lauroyl-gemcitabine loaded lipid nanocapsules for the

treatment of metastases in mediastinal lymph nodes

Nathalie Wauthoz, Elodie Moysan, Kazuya Kondo, Marc Zandecki, Valérie

Moal, Marie-Christine Rousselet, José Hureaux, Guillaume Bastiat,

Jean-Pierre Benoit

To cite this version:

Nathalie Wauthoz, Elodie Moysan, Kazuya Kondo, Marc Zandecki, Valérie Moal, et al..

Lauroyl-gemcitabine loaded lipid nanocapsules for the treatment of metastases in mediastinal lymph nodes.

9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Mar 2014,

Lisbon, Portugal. 2014. �hal-03173099�

(2)

!

"

#

_$

#

_{% &}

#

' (

)

#

_{* +}

_{' , +}

!"

# $%%&&

'

#

() ' ((

*+

,

'

*-. / 0

-1

( '

(

-"

(2

32 4 -3 5 2

3 5 2

66 78 & 9 0

*

& "

( '4

2 4 ! ((

3 : 2 ( '4

:

( '4 / 0

"

0 (

'

# $%%&& #

*

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ve (nm) PdI -Potc (mV) 21 &/ 3 / 0-4- 0 * %-.2+- 5 / 20 0 -,-0 2 / %2,61 6 / ( ,2.- . - 3 ,( / * / 1 6 .26.2.-% ,& % - -%2 / 0 + + -/ / ! 2 (24 -C < ( > -/ / ! 0 < 0 ( = ! .>

+-/ 0-6.&-+1 .-/ - ( 2 .( 3 2 0 .1 / & + 2&- * -%

N N O O OH HO F HN F (nm) PdI (mV) Non-loaded LNC (iv) 68 ± 3 0.08 ± 0.02 -8 ± 3 Non-loaded LNC (sc) 67 ± 2 0.07 ± 0.01 -10 ± 5 LNC Gem-C12 (sc) 53± 2 0.07 ± 0.01 -7 ± 4 LNC Gem-C12 (iv) 53 ± 1 0.04 ± 0.01 -7 ± 3 DiD-Gem-C12 loaded LNC (sc) 56 ± 2 0.04 ± 0.02 -5 ± 2 DiD-non-loaded LNC (iv) 55 ± 2 0.06 ± 0.02 -7 ± 4 4( - = + <= ! .> ; 00 2 (0 0 ( < !> - ' - ( 0 24 ' ( ; + ; 2 ! * :24 2 ( 2 -( ( ! -C < D&E F / >* / ( ! ( C C # 1 B ( . $ 7 89 0 ( 4 0( 0 0 <- #>* < > ' <0 5 ; 2 0 (4> - 4 . 0 ' - E 2 ( ' ( ( -( ' + ' 2 $$ & < !>* ! / ! 6 - 2 ( < 2 _{4 0} _{' - >} - ((0 4 ( ' * ( ( 0( (( (4 02 ; + ; 2 / / ( ! 0 (4 ( * / / = ! . ( ! ' ( -+ (4 ( ( A ( (4 2 (4 02 ( 2 C 0 4 ( ; 4 A0 *

2 +

C < ( > -/ / ! 0 < 0 ( = ! .> < > + C <+ 2 2 5> - / / ! 24 ' (<8? = ! .G + - ; G; > <! / >* - -2 -( ' ( - 2 ( 0( ' ( A (( 4 ( + 2 ( (4 02 < > ' -( ' < ' > ! < $ 7 $7 % && 2>* < D8 ± />*

DID visualization mode Pp IX visualization mode sc administration sc administration 0 4 ( ; 4 A0 * H 2 + ' ! / ! 6 / / ! ; +( 2 ( ' - 2 2 - C * 1 2 4 / / ! +4 ( ( ( ((4 02 *

+

0

@ (I - ( ' - 2 4 8 - 0( - (( ; ' ( -$ 'G5' -8 ( ( - ! ( ; 2 / / + (4 ( <; 2 = ! .> ' < > :0 J < > / / (I E (4 ( <; 2 = ! .> ' <!> :0 J </ > / / (I ' ! 4 * ; 0 2 ( (I

-DID visualization mode Pp IX visualization mode iv administration iv administration +% : ; < &+% : ; < ( *+ : ; < ( %. := < , . : ; < 6 *. F * %*7 F *& 8* F *& $6 F $ % F 8 * *. F * %*. F *& $* F *$ $8 F 9> ? @# A * % *& F *. %* F * $ F $8 F . .68 F & % * F *& %*7 F *. 8* F *& $6*6 F *% $ 8 F $$ % * % * $ F * & 7*% F *. &*6 F *& $&* F *% .7$ F .$ % *$ F * %*$ F *6 $ F $ F & $8& F . 2 .-.1 / & 44-%2%3 2 0 ./ &2 % / 4 .& 2. .6

' ! 4 * ; 0 2 ( (I

-((4 02 2 0 * iv administration DID visualization mode

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